Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 11, 2016 - Issue
Submit an article Journal homepage
107
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Effects of long-term bronchodilators in bronchiectasis patients with airflow limitation based on bronchodilator response at baseline

Ho Jung Jeong1 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University of Medicine, Seoul, South Korea
,
Hyun Lee1 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University of Medicine, Seoul, South Korea
,
Keumhee C Carriere2 Department of Mathematical and Statistical Sciences, University of Alberta, Edmonton, AB, Canada;3 Biostatistics and Clinical Epidemiology Center, Samsung Medical Center, Seoul, South Korea
,
Jung Hoon Kim1 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University of Medicine, Seoul, South Korea
,
Jin-Hyung Han1 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University of Medicine, Seoul, South Korea
,
Beomsu Shin1 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University of Medicine, Seoul, South Korea
,
Byeong-Ho Jeong1 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University of Medicine, Seoul, South Korea
,
Won-Jung Koh1 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University of Medicine, Seoul, South Korea
,
O Jung Kwon1 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University of Medicine, Seoul, South Korea
&
Hye Yun Park1 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University of Medicine, Seoul, South KoreaCorrespondence[email protected]
 show all
Pages 2757-2764 | Published online: 07 Nov 2016

References

  • AmalakuhanBMaselliDJMartinez-GarciaMAUpdate in Bronchiectasis 2014Am J Respir Crit Care Med2015192101155116126568240
  • ColePJInflammation: a two-edged sword – the model of bronchiectasisEur J Respir Dis Suppl19861476153533593
  • RobertsHRWellsAUMilneDGAirflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function testsThorax200055319820410679538
  • HoPLChanKNIpMSThe effect of Pseudomonas aeruginosa infection on clinical parameters in steady-state bronchiectasisChest19981146159415989872194
  • NogradySGEvansWVDaviesBHReversibility of airways obstruction in bronchiectasisThorax1978335635637725832
  • PangJChanHSSungJYPrevalence of asthma, atopy, and bronchial hyperreactivity in bronchiectasis: a controlled studyThorax198944119489512595637
  • PasteurMCBiltonDHillATBritish Thoracic Society guideline for non-CF bronchiectasisThorax201065Suppl 1i1i5820627931
  • McShanePJNaureckasETTinoGStrekMENon-cystic fibrosis bronchiectasisAm J Respir Crit Care Med2013188664765623898922
  • Martínez-GarcíaMAPerpiñá-TorderaMRomán-SánchezPSoler-CataluñaJJInhaled steroids improve quality of life in patients with steady-state bronchiectasisRespir Med200610091623163216434174
  • TsangKWTanKCHoPLInhaled fluticasone in bronchiectasis: a 12 month studyThorax200560323924315741443
  • WongCJayaramLKaralusNAzithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trialLancet2012380984266066722901887
  • AltenburgJde GraaffCSStienstraYEffect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trialJAMA2013309121251125923532241
  • SerisierDJMartinMLMcGuckinMAEffect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trialJAMA2013309121260126723532242
  • HassanJASaadiahSRoslanHZainudinBMBronchodilator response to inhaled beta-2 agonist and anticholinergic drugs in patients with bronchiectasisRespirology19994442342610612580
  • TashkinDKestenSLong-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responsesChest200312351441144912740259
  • SheikhANolanDGreenstoneMLong-acting β2-agonists for bronchiectasisCochrane Database Syst Rev20014CD00215511687145
  • FrancoFSheikhAGreenstoneMShort acting β2 agonists for bronchiectasisCochrane Database Syst Rev20033CD00357212917973
  • GuanWJGaoYHXuGBronchodilator response in adults with bronchiectasis: correlation with clinical parameters and prognostic implicationsJ Thorac Dis201681142326904207
  • MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
  • ChoiJKPaekDMLeeJONormal predictive values of spirometry in Korean populationTuberc Respir Dis2005583230242
  • PellegrinoRViegiGBrusascoVInterpretative strategies for lung function testsEur Respir J200526594896816264058
  • DoddJDLavelleLPFabreABradyDImaging in cystic fibrosis and non-cystic fibrosis bronchiectasisSemin Respir Crit Care Med201536219420625826587
  • HansellDMBankierAAMacMahonHMcLoudTCMüllerNLRemyJFleischner Society: glossary of terms for thoracic imagingRadiology2008246369772218195376
  • CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
  • RennardSIAndersonWZuWallackRUse of a long-acting inhaled β2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116351087109211316640
  • ZuWallackRLMahlerDAReillyDSalmeterol plus theophylline combination therapy in the treatment of COPDChest200111961661167011399688
  • BleeckerEREmmettACraterGKnobilKKalbergCLung function and symptom improvement with fluticasone propionate/salmeterol and ipratropium bromide/albuterol in COPD: response by beta-agonist reversibilityPulm Pharmacol Ther200821468268818541448
  • MahlerDADonohueJFBarbeeRAEfficacy of salmeterol xinafoate in the treatment of COPDChest1999115495796510208192
  • TashkinDPCelliBDecramerMBronchodilator responsiveness in patients with COPDEur Respir J200831474275018256071
  • MaoBYangJWLuHWXuJFAsthma and bronchiectasis exacerbationEur Respir J20164761680168627076584
  • SaynajakangasOKeistinenTTuuponenTKivelaSLLinks between hospital diagnoses of bronchiectasis and asthmaAllergy19975211112011229404566

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.